Announcements Trials
Browse Landscape

Phase

Phase 2 11Phase 1 4Phase 1/2 3Phase 3 2

Status

Completed 2

Sponsor Class

NIH 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Melanoma 4Neoplasms 2Leukemia, Myeloid, Acute 2Breast Neoplasms 2Sepsis 1Sarcoma 1Rhabdomyosarcoma 1Prostatic Neoplasms 1Pathologic Complete Response 1Neutropenia 1Neuroblastoma 1Neoplasm Metastasis 1Multiple Myeloma 1Malignant mesenchymal tumor 1Lymphoma, Non-Hodgkin 1Lymphoma 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Hematologic Diseases 1Graft vs Host Disease 1Gliosarcoma 1Glioblastoma 1Fever 1Carcinoma, Renal Cell 1Brain Neoplasms 1

Interventions

Cyclophosphamide 149Docetaxel 139Paclitaxel 127Trastuzumab 120Tamoxifen 110Capecitabine 104Letrozole 92Epirubicin 79Doxorubicin 70Anastrozole 70exemestane 67Fulvestrant 65Fluorouracil 61Radiotherapy 60pertuzumab 40Gemcitabine 39Carboplatin 38Vinorelbine 34Goserelin 34Bevacizumab 29Zoledronic Acid 28Methotrexate 28Chemotherapy, Adjuvant 28eribulin 27Lapatinib 25ribociclib 24palbociclib 24Drug Therapy 22130-nm albumin-bound paclitaxel 20pegfilgrastim 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Breast Neoplasms × Granulocyte-Macrophage Colony-Stimulating Factor × Clear all
NCT01479244 2017-02-27

PRESENT

Galena Biopharma, Inc.

Phase 3 Completed
758 enrolled
Breast

Breast Neoplasms

NCT00001338 2008-03-04

A Prospective, Randomized, Phase III Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Chemotherapy With GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor) Versus PIXY 321 in Advanced Breast Cancer

National Institutes of Health Clinical Center (CC)

Phase 3 Completed
65 enrolled
Breast

Breast Neoplasms, Fever, Hematologic Diseases, Neutropenia, Sepsis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡